My watch list
my.bionity.com  
Login  

Duke University

News Duke University

  • Engineered bacteria can make the ultimate sacrifice

    Scientists have engineered bacteria that are capable of sacrificing themselves for the good of the bacterial population. These altruistically inclined bacteria, which are described in the journal Molecular Systems Biology, can be used to demonstrate the conditions where programmed cell death becomes more

  • Gene required for nerve regeneration identified

    A gene that is associated with regeneration of injured nerve cells has been identified by scientists at Penn State University and Duke University. The team, led by Melissa Rolls, an assistant professor of biochemistry and molecular biology at Penn State, has found that a mutation in a single gene ca more

  • Duke researchers engineer cartilage from pluripotent stem cells

    A team of Duke Medicine researchers has engineered cartilage from induced pluripotent stem cells that were successfully grown and sorted for use in tissue repair and studies into cartilage injury and osteoarthritis. The finding is reported in Proceedings of the National Academy of Sciences, and sugg more

All news on duke university

Publications Duke University

All publications on duke university

Market studies Duke University

  • Stem Cell Technologies: World Market Outlook 2011-2021

    How will the stem cells market develop this decade? Our new report shows you that emerging industry and market's revenue potential from 2011 to 2021. This report covers stem cells in therapeutic applications: technologies, products and services. You will assess events, opportunities and activities more

  • World Anti-Obesity Drug Market 2011-2021

    What will this decade hold for the challenged anti-obesity drug industry and market? Our new report gives you revenue forecasts at world, product and national level. We provide original research, data and opinions to benefit your work. By ordering now, you can stay ahead. We aim to save you time a more

  • Bradmer Pharmaceuticals Inc. (BMR) - Financial and Strategic SWOT Analysis Review

    Bradmer Pharmaceuticals Inc. (Bradmer) is a publicly held life sciences company that is engaged in the development and marketing of drugs for the treatment of cancer. The company focuses on the treatment of Glioblastoma multiforme (GBM), an aggressive form of brain cancer. Its lead product include N more

All market studies on duke university

Websites Duke University

Bradmer Pharmaceuticals

           HOME INVESTORS             ABOUT US Bradmer Pharmaceuticals, Inc. is dedicated to the development and commercialization of new and innovative cancer therapies. We Identify, license, clinically test, and bring to market promising new anti-cancer drugs that have been discovered at leading a more

Recent News - News and Events - Pieris AG

  Recent News Upcoming Events     Recent News Pieris AG Appoints Chief Scientific Officer   Freising-Weihenstephan, Germany, June 7, 2010.   Pieris AG announced today that Laurent Audoly, Ph.D., has joined the company as Chief Scientific Officer, effective immediately.  Dr. Audoly, most recently Bio more

Testimonials - Users of Catalog or Custom, Monoclonal & Polyclonal Antibodies

Login | View Cart Part of Thermo Fisher Scientific Products Product Search Cell Biology Cell Signalling Disease Muscle Biology Neurobiology Stem Cell Biology Controls, Secondaries & Tags Products by Species Products by Catalog Number Products by Name (alphabetical) Technical Resources FAQ Protocols more

All websites on duke university

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE